BlockQuarry Corp (BLQC): Ramping Up: Sub-Penny ISWH to Resume CBD...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	16
Posts	1381
Boards Moderated	0
Alias Born	02/09/2017

Daddy Rick

Re: None

Thursday, 09/19/2019 8:25:13 AM

Thursday, September 19, 2019 8:25:13 AM

Ramping Up: Sub-Penny ISWH to Resume CBD Sales After Turning Profitable

There is an interesting story brewing in the sub-penny ranks right now. International Spirits & Wellness Holdings, Inc. (OTCMKTS: ISWH), a company that specializes in premium tequila, home healthcare, and CBD-based wellness products, just put out wordthat it was heading for its first ever EBITDA profitable quarter in Q3 of this year – when the quarter ends on September 30.

This news followed tightly on the heels of the company’s pronouncement that it saw revenues grow by 6,400% in the prior quarter – ending June 30.

According to company communications, the x-factor here has been its success in the home health care space, where it has been significant strides toward growth and profitability – strides that are now coming to fruition in Q3.

The Bigger Story

But there’s a bigger story lurking under the surface of this evolving turnaround narrative: the company’s branded CBD-based product segment has been largely on hold in recent months following a strong growth trend put into place during Q4 2018 and Q1 2019. The reason this stock is really worth a look is that the company just announced the CBD business is ready to ramp back up after some reconfiguring of its supply chain and its key strategic partnership with BioPulse Labs, one of the foremost players in the CBD nano-infusion technology space. BioPulse is also critical to ISWH’s marketing and distribution strategy for its P19 CBD line.

So, news that the partnership and process is now fully coming back online opens up a very different level of growth potential as we look ahead to how this story might further evolve from now until year end.

Simply put, this is a monumental turnaround story in terms of tangible financial performance. The growth on the top-line is in place. The EBITDA profitability is now in place as well. And now, it looks an awful lot like we are about to see the extra growth engine of multi-segment performance start to kick into gear as CBD sales ramp back up.....
MORE:

https://www.journaltranscript.com/2019/09/ramping-up-sub-penny-iswh-to-resume-cbd-sales-after-turning-profitable/